2 studies found for:    12065559 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure
Condition: Soft Tissue Sarcoma
Intervention: Drug: LBH589 (Panobinostat®)
2 Completed Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Conditions: Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Biological: filgrastim;   Drug: docetaxel;   Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years